13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001166309
Total reported value
$150.1M
$150.1M
28 檔
65.1%
In Q2 2024, Bridger Management, LLC's U.S. equity holdings reached a combined market value of $150.1M, distributed across 28 disclosed stock positions.
In Q2 2024, Bridger Management, LLC adopted a defensive or profit-taking posture, trimming 4 positions and completely liquidating 5 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | Stock-Healthcare | 11.51% | +1.27% | -11.98% | |
| 2 | UBER | Uber Technologies Inc | Stock-Industrials | 11.27% | -0.47% | — | |
| 3 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 9.90% | — | — | |
| 4 | MS | Morgan Stanley | Stock-Financials | 9.39% | +1.20% | — | |
| 5 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 8.20% | -0.35% | -34.60% | |
| 6 | PFE | Pfizer Inc | Stock-Healthcare | 5.05% | — | — | |
| 7 | TSM | Taiwan Semiconductor-sp Adr | Stock-Tech | 4.64% | — | — | |
| 8 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 4.63% | — | -30.04% | |
| 9 | BBWI | Bath & Body Works Inc | Stock-Consumer Disc | 4.46% | — | -14.13% | |
| 10 | BLCO | Bausch + Lomb CORP | Stock-Other | 3.78% | — | — | |
| 11 | MLCO | Melco Resorts & Entert-adr | Stock-Other | 3.78% | -0.48% | +13.71% | |
| 12 | CZR | Caesars Entertainment Inc | Stock-Consumer Disc | 3.02% | — | — | |
| 13 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 2.95% | — | — | |
| 14 | GERN | Geron CORP | Stock-Other | 2.92% | — | — | |
| 15 | SWTXUSD | Springworks Therapeutics Inc | Stock-Other | 2.80% | — | — | |
| 16 | DXCM | Dexcom Inc | Stock-Healthcare | 1.69% | -0.43% | — | |
| 17 | CPRX | Catalyst Pharmaceuticals Inc | Stock-Healthcare | 1.47% | — | — | |
| 18 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 1.30% | +0.25% | — | |
| 19 | QTRX | Quanterix CORP | Stock-Other | 1.05% | — | — | |
| 20 | ✓ | Hillevax Inc | Stock-Other | 1.04% | — | +29.48% | |
| 21 | MSFT | Microsoft CORP | Stock-Tech | 0.97% | -0.50% | — | |
| 22 | 430 | Terns Pharmaceuticals Inc | Stock-Other | 0.86% | — | — | |
| 23 | QURE | uniQure N.V. | Stock-Other | 0.84% | — | — | |
| 24 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 0.78% | +3.28% | NEW | |
| 25 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 0.72% | -0.25% | — | |
| 26 | TOST | Toast Inc-class A | Stock-Tech | 0.70% | -0.09% | — | |
| 27 | NEXT | Nextdecade CORP | Stock-Other | 0.28% | -0.07% | — | |
| 28 | SRZNW | Surrozen Inc-cw25 | Stock-Other | — | -0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BLCO | Bausch + Lomb CORP | +3.8% | NEW | New buy |
| 2 | VRTX | Vertex Pharmaceuticals Inc | +2.2% | — | Unchanged |
| 3 | LLY | Eli Lilly & Co | +1.7% | -11.98% | Trim |
| 4 | TSM | Taiwan Semiconductor-sp Adr | +1.5% | — | Unchanged |
| 5 | MS | Morgan Stanley | +1.4% | — | Unchanged |
| 6 | ALNY | Alnylam Pharmaceuticals Inc | +1.1% | -30.04% | Trim |
| 7 | MLCO | Melco Resorts & Entert-adr | +1% | +13.71% | Add |
| 8 | GERN | Geron CORP | +0.9% | — | Unchanged |
| 9 | UBER | Uber Technologies Inc | +0.8% | — | Unchanged |
| 10 | OSCR | Oscar Health Inc - Class A | +0.8% | NEW | New buy |
| 11 | PFE | Pfizer Inc | +0.7% | — | Unchanged |
| 12 | GOOGL | Alphabet Inc-cl A | +0.4% | — | Unchanged |
| 13 | ✓ | Hillevax Inc | +0.2% | +29.48% | Add |
| 14 | MSFT | Microsoft CORP | +0.2% | — | Unchanged |
| 15 | CPRX | Catalyst Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 16 | AMZN | Amazon.com Inc | +0.1% | — | Unchanged |
| 17 | 430 | Terns Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 18 | CZR | Caesars Entertainment Inc | +0.1% | — | Unchanged |
| 19 | NEXT | Nextdecade CORP | +0.1% | — | Unchanged |
| 20 | TOST | Toast Inc-class A | +0.1% | — | Unchanged |
| 21 | XENE | Xenon Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 22 | QURE | uniQure N.V. | 0% | — | Unchanged |
| 23 | SRZNW | Surrozen Inc-cw25 | 0% | — | Unchanged |
| 24 | DXCM | Dexcom Inc | -0.1% | — | Unchanged |
| 25 | SWTXUSD | Springworks Therapeutics Inc | -0.4% | — | Unchanged |
| 26 | QTRX | Quanterix CORP | -0.6% | — | Unchanged |
| 27 | SPOT | Spotify Technology S.A. | -0.6% | EXIT | Sold out |
| 28 | TEVA | Teva Pharmaceutical-sp Adr | -1.3% | -34.60% | Trim |
| 29 | BBWI | Bath & Body Works Inc | -1.4% | -14.13% | Trim |
| 30 | ATRC | Atricure Inc | -1.4% | EXIT | Sold out |
| 31 | CYTK | Cytokinetics Inc | -2.2% | EXIT | Sold out |
| 32 | THC | Tenet Healthcare CORP | -4.2% | EXIT | Sold out |
| 33 | 0C3 | Endeavor Group Hold-class A | -5.1% | EXIT | Sold out |
According to official SEC Form 13F filings, Bridger Management, LLC reported a total U.S. public equity portfolio value of $150.1M across 28 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including LLY, UBER, VRTX) accounted for 65.1% of total reported equity market value during Q2 2024.
Top New Position Initiated
BLCO
市值: $7.4M
Top Position Liquidated / Trimmed
0C3
前期市值: $11.4M
During Q2 2024, Bridger Management, LLC's top holdings by market value included LLY (11.5%)、UBER (11.3%)、VRTX (9.9%). The largest single position, LLY, represented 11.5% of total portfolio value.
In Q2 2024, Bridger Management, LLC made 13 total portfolio adjustments, initiating 2 new buys, adding to 2 positions, trimming 4 holdings, and fully liquidating 5 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.